Life sciences

SPECIAL FEATURE

Living your best life the Holistic Way

2026-09-25T03:30:00.000Z
Life sciences is an ideal sector for the UK and Singapore to pilot a trade accelerator. The UK brings world-leading research, clinical expertise and a pipeline of companies while Singapore brings a sophisticated regulatory environment, deep capital markets and a strong biomedical ecosystem.

Trade deals open doors. Someone still has to walk through them

2026-09-07T23:00:00.000Z
AI systems are expected to reshape how new drugs are discovered and developed.
DUE DILIGENCE

AI for life science: Queen’s Gambit or fool’s wager?

2026-08-10T23:00:00.000Z
The advancements made by the joint research will enable Singapore companies to better serve clients in the aerospace and semiconductor sectors, among others.

Stronger, tougher, cleaner: A*Star and local companies find new solutions in advanced manufacturing

2025-10-15T01:00:00.000Z
Born in London on Apr 3, 1934, Goodall grew fascinated with animals in her early childhood, when her father gave her a stuffed toy chimpanzee that she kept for life.
OBITUARY

World-renowned chimpanzee expert Jane Goodall dies at 91

2025-10-02T02:19:28.000Z
Javier Bilbao, CEO Asia-Pacific at DHL Supply Chain, says that tariffs mean logistics expertise will be in more demand than ever.
TOPLINE

DHL banks on burgeoning markets like South-east Asia as it aims for 50% revenue growth by 2030 

2025-04-28T07:27:50.000Z
Whether it’s lab-grown meats or bioengineered materials, the scope of synthetic biology reaches far beyond traditional scientific innovation – it has the power to radically reshape industries, economies, and even social norms.
WEALTH & INVESTING

Investing in synthetic biology: Rewriting life’s code

2025-01-24T21:00:00.000Z
The Business Times reported in May 2023 that AcroMeta, which launched Life Science Incubator in 2021, was eyeing further expansion.

AcroMeta to divest life-sciences business, pursue minerals trading business

2024-10-21T14:59:16.000Z
Merck narrowed expectations for its Life Science business, aiming for annual organic sales growth in a 7-to-9 per cent range from a previously anticipated 7 to 10 per cent.

Germany’s Merck open to more M&A for its Life Science division

2024-10-17T08:37:25.000Z
Elementum, Ho Bee Land’s landmark biomedical life-science development. The group is selling a 49 per cent stake in this project to a sovereign wealth fund.

Ho Bee Land sells 49% stake in Elementum for S$134 million to sovereign wealth fund

2024-08-12T08:29:47.000Z